Skip to main content

Advertisement

SpringerLink
Log in

Immune response in progressive multifocal leukoencephalopathy: An overview

  • Immunovirology Report
  • Published:
Journal of NeuroVirology Aims and scope Submit manuscript

Abstract

Progressive multifocal leukoencephalopathy (PML) is a disease usually ocurring in immunosuppressed patients. By far the most common underlying immunosuppressive illness is the acquired immune deficiency snydrome, accounting for about 85% of PML cases currently seen in clinical practice. PML may occur in patients with deficits in the humoral and/or cellular immune response such as lymphoproliferative diseases, myeloproliferative diseases, carcinomatous diseases and acquired immunodeficiency due to autoimmune diseases and immunosuppressive therapy. The humoral immune response in PML is indicative of a persistent, reactivated infection with a prominent immunoglobulin (lgG) G synthesis to virus protein 1 (VP1). An lgM synthesis in serum is rarely found. In about 76% of PML cases, an intrathecal humoral immune response to recombinant VP1 can be found as compared to only 3.2% in healthy controls. The detection of intrathecally synthesized lgG antibodies to VP1 can be used as an additional diagnostic test for the diagnosis of PML. The magnitude of the intrathecal humoral immune response appears to rise over time and may be associated with a decrease of viral load in cerebrospinal fluid (CSF) and possibly the central nervous system (CNS). Compared to healthy controls, proliferation of peripheral blood mononuclear cells (PBMC) is reduced in PML patients. Immunological studies suggest a general impairment of the Th1-type T-helper cell function of cell-mediated immunity. Furthermore, the appearance of JCV-specific cytotoxic T-lymphocytes appears to be associated with a favorable clinical outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Albrecht H, Hoffmann C, Degen O, Stoehr A, Plettenberg A, Mertenskotter T, Eggers C, Stellbrink HJ (1998). Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopahty. AIDS 12: 1149–1154.

    Article  CAS  PubMed  Google Scholar 

  • Åström K-E, Mancall EL, Richardson EP (1958). Progressive multifocal leukoencephalopathy. A hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin’s disease. Brain 81: 93–111.

    Article  PubMed  Google Scholar 

  • Baldeweg T, Catalan J (1997). Remission of progressive multifocal leucoencephalopathy after antiretroviral therapy. Lancet 349: 1554–1555.

    Article  CAS  PubMed  Google Scholar 

  • Baqi M, Kucharczyk W, Walmsley SL (1997). Regression of progressive multifocal encephalopathy with highly active antiretroviral therapy. AIDS 11: 1526–1527.

    CAS  PubMed  Google Scholar 

  • Berger JR, Kaszovitz B, Post MJ, Dickinson G (1987). Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. Ann intern Med 107: 78–87.

    CAS  PubMed  Google Scholar 

  • Berger JR, Levy RM, Flomenhoft D, Dobbs M (1998). Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 44: 341–349.

    Article  CAS  PubMed  Google Scholar 

  • Berner B, Krieter DH, Rumpf KW, Grunewald RW, Beuche W, Weber T, et al (1999). Progressive multifocal leukoencephalopathy in a renal transplant patient diagnosed by JCV-specific DNA amplification and an intrathecal humoral immune response to recombinant virus protein 1. Nephrol Dial Transplant 14: 462–465.

    Article  CAS  PubMed  Google Scholar 

  • Budka H, Shah KV (1983). Papovavirus antigens in paraffin sections of PML brains. Prog Clin Biol Res 105: 299–309.

    CAS  PubMed  Google Scholar 

  • De Luca A, Giancola ML, Cingolani A, Ammassari A, Gillini L, Murri R, Antinori A (1999). Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 28: 624–628.

    Article  PubMed  Google Scholar 

  • Domingo P, Guardiola JM, Iranzo A, Margall N (1997). Remission of progressive multifocal leucoencephalopathy after antiretroviral therapy. Lancet 349: 1554–1555.

    Article  CAS  PubMed  Google Scholar 

  • Dworkin MS, Wan PC, Hanson DL, Jones JL (1999). Progressive multifocal leukoencephalopathy: improved survival of human immunodeficiency virus-infected patients in the protease inhibitor era. J Infect Dis 180: 621–625.

    Article  CAS  PubMed  Google Scholar 

  • Eggers C, Stellbrink HJ, Buhk T, Dörries K (1999). Quantification of JC virus DNA in the cerebrospinal fluid of patients with human immunodeficiency virus-associated progressive multifocal leukoencephalopathy—a longitudinal study. J Infect Dis 180: 1690–1694.

    Article  CAS  PubMed  Google Scholar 

  • Elliot B, Aromin I, Gold R, Flanigan T, Mileno M (1997). 2.5 year remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy. Lancet 349: 850.

    Article  CAS  PubMed  Google Scholar 

  • Ellison GW (1969). Progressive multifocal leukoencephalopathy (PML). I. Investigation of the immunologic status of a patient with lymphosarcoma and PML. J Neuropathol Exp Neurol 28: 501–506.

    Article  CAS  PubMed  Google Scholar 

  • Frye S, Trebst C, Dittmer U, Petry H, Bodemer M, Hunsmann G, Weber T, Lüke W (1997). Efficient production of JC virus in SVG cells and the use of purified viral antigens for analysis of specific humoral and cellular immune response. J Virol Methods 63: 81–92.

    Article  CAS  PubMed  Google Scholar 

  • Gasnault J, Taoufik Y, Goujard C, Kousignian P, Abbed K, Boue F, Dussaix E, Delfraissy JF (1999). Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy. J NeuroVirol 5: 421–429.

    Article  CAS  PubMed  Google Scholar 

  • Giudici B, Vaz B, Bossolasco S, Casari S, Brambilla AM, Luke W, et al (2000). Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 30: 95–99.

    Article  CAS  PubMed  Google Scholar 

  • Goldmann C, Petry H, Frye S, Ast O, Ebitsch S, Jentsch KD, et al (1999). Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: formation of virus-like particles useful for immunological and therapeutic studies. J Virol 73: 4465–4469.

    CAS  PubMed  Google Scholar 

  • Guillaume B, Sindic CJ, Weber T (2000). Progressive multifocal leukoencephalopathy: simultaneous detection of JCV DNA and anti-JCV antibodies in the cerebrospinal fluid. Eur J Neurol 7: 101–106.

    Article  CAS  PubMed  Google Scholar 

  • Inui K, Miyagawa H, Sashihara J, Miyoshi H, Tanaka-Taya K, Nishigaki T, et al (1999). Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a patient with HIV infection. Brain Dev 21: 416–419.

    Article  CAS  PubMed  Google Scholar 

  • Katz DA, Berger JR, Hamilton B, Major EO, Post MJ (1994). Progressive multifocal leukoencephalopathy complicating Wiskott—Aldrich syndrome. Report of a case and review of the literature of progressive multifocal leukoencephalopathy with other inherited immunodeficiency states. Arch Neurol 51: 422–426.

    CAS  PubMed  Google Scholar 

  • Knight A, O’Brien P, Osoba D (1972). “Spontaneous” progressive multifocal leukoencephalopathy. Immunologic aspects. Ann Intern Med 77: 229–233.

    CAS  PubMed  Google Scholar 

  • Knowles WA, Luxton RW, Hand JF, Gardner SD, Brown DWG (1995). The JC virus antibody response in serum and cerebrospinal fluid in progressive multifocal leucoencephalopathy. Clin Diag Virol 4: 183–194.

    Article  CAS  Google Scholar 

  • Koralnik IJ, Boden D, Mai VX, Lord CI, Letvin NL (1999). JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology 52: 253–260.

    CAS  PubMed  Google Scholar 

  • Koralnik IJ, Du Pasquier R, Pfister L-A, Letvin NL (2000). JC virus-specific cytotoxic T lymphocytes in patients with AIDS-associated progressive multifocal leukoencephalopathy. Neurology 753: A173.

    Google Scholar 

  • Kuchelmeister K, Gullotta F, Bergmann M, Angeli G, Masini T (1993). Progressive multifocal leukoencephalopathy (PML) in the acquired immunodeficiency syndrome (AIDS). A neuropathological autopsy study of 21 cases. Pathol Res Pract 189: 163–173.

    CAS  PubMed  Google Scholar 

  • Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR (1992). Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 5: 49–73.

    CAS  PubMed  Google Scholar 

  • Major EO, Ault GS (1995). Progressive multifocal leukoencephalopathy: clinical and laboratory observations on a viral induced demyelinating disease in the immunodeficient patient. Curr Opin Neurol 8: 184–190.

    Article  CAS  PubMed  Google Scholar 

  • Miralles P, Berenguer J, Garcia de Viedma D, Padilla B, Cosin J, Lopez-Bernaldo de Quiros JC, Munoz L, Moreno S, Bouza E (1998). Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 12: 2467–2472.

    Article  CAS  PubMed  Google Scholar 

  • Monno L, Zimatore GB, Di Stefano M, Appice A, Livrea P, Angarano G (1999). Reduced concentrations of HIV-RNA and TNF-alpha coexist in CSF of AIDS patients with progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry 67: 369–373.

    Article  CAS  PubMed  Google Scholar 

  • Owen RG, Patmore RD, Smith GM, Barnard DL (1995). Cytomegalovirus-induced T-cell proliferation and the development of progressive multifocal leucoencephalopathy following bone marrow transplantation. Br J Haematol 89: 196–198.

    Article  CAS  PubMed  Google Scholar 

  • Padgett BL, Walker DL (1973). Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J Infect Dis 127: 467–470.

    CAS  PubMed  Google Scholar 

  • Padgett BL, Walker DL (1976). New human papovaviruses. Prog Med Virol 22: 1–35.

    CAS  PubMed  Google Scholar 

  • Padgett BL, Walker DL (1983). Virologic and serologic studies of progressive multifocal leukoencephalopathy. ProgClin Biol Res 105: 107–117.

    CAS  Google Scholar 

  • Padgett BL, Walker DL, ZuRhein GM, Hodach AE, Chou SM (1976). JC Papovavirus in progressive multifocal leukoencephalopathy. J Infect Dis 133: 686–690.

    CAS  PubMed  Google Scholar 

  • Peters AC, Versteeg J, Bots GT, Boogerd W, Vielvoye GJ (1980). Progressive multifocal leukoencephalopathy: immunofluorescent demonstration of simian virus 40 antigen in CSF cells and response to cytarabine therapy. Arch Neurol 37: 497–501.

    CAS  PubMed  Google Scholar 

  • Power C, Nath A, Aoki FY, Bigio MD (1997). Remission of progressive multifocal leukoencephalopathy following splenectomy and antiretroviral therapy in a patientwith HIV infection. N Engl J Med 336: 661–662.

    Article  CAS  PubMed  Google Scholar 

  • Reiber H, Felgenhauer K (1987). Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta 163: 319–328.

    Article  CAS  PubMed  Google Scholar 

  • Reiber H, Lange P (1991). Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 37: 1153–1160.

    CAS  PubMed  Google Scholar 

  • Richardson EPJ (1961). Progressive multifocal leukoencephalopathy. N Engl J Med 265: 815–823.

    Article  PubMed  Google Scholar 

  • Rockwell D, Ruben FL, Winkelstein A, Mendelow H (1976). Absence of imune deficiencies in a case of progressive multifocal leukoencephalopathy. Am J Med 61: 433–436.

    Article  CAS  PubMed  Google Scholar 

  • Sindic CJ, Monteyne P, Laterre EC (1994). The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis. J Neuroimmunol 54: 75–80.

    Article  CAS  PubMed  Google Scholar 

  • Sindic CJ, Trebst C, Van Antwerpen MP, Frye S, Enzensberger W, Hunsmann G, et al (1997). Detection of CSF-specific oligoclonal antibodies to recombinant JC virus VP1 in patients with progressive multifocal leukoencephalopathy. J Neuroimmunol 76: 100–104.

    Article  CAS  PubMed  Google Scholar 

  • Tantisiriwat W, Tebas P, Clifford DB, Powderly WG, Fichtenbaum CJ (1999). Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy. Clin Infect Dis 28: 1152–1154.

    Article  CAS  PubMed  Google Scholar 

  • Taoufik Y, Delfraissy JF, Gasnault J (2000). Highly active antiretroviral therapy does not improve survival of patients with high JC virus load in the cerebrospinal fluid at progressive multifocal leukoencephalopathy diagnosis. AIDS 14: 758–759.

    Article  CAS  PubMed  Google Scholar 

  • Teofilo E, Gouveia J, Brotas V, da Costa P (1998). Progressive multifocal leukoencephalopathy regression with highly active antiretroviral therapy. AIDS 12: 449.

    CAS  PubMed  Google Scholar 

  • Walker DL (1985). Progressive multifocal leukoencephalopathy. In: Vinken PJ, Bruyn GW, Klawans HL, (eds). Handbook of clinical neurology, demyelinating diseases, Vol 47 (3). Amsterdam: Elsevier Science Publishers, pp 503–524.

    Google Scholar 

  • Weber T, Freter A, Luer W, Haas J, Stark E, Poser S, et al (1991). The use of recombinant antigens in ELISA procedures for the quantification of intrathecally produced HIV-1-specific antibodies. J Immunol Methods 136: 133–137.

    Article  CAS  PubMed  Google Scholar 

  • Weber T, Frye S, Bodemer M, Otto M, Lüke W (1996). Clinical implications of nucleic acid amplification methods for the diagnosis of viral infections of the nervous system. J NeuroVirol 2: 175–190.

    Article  CAS  PubMed  Google Scholar 

  • Weber F, Goldmann C, Krämer M, Kaup FJ, Pickhardt M, Young P, et al (2001). Humoral and cellular immune response in progressive multifocal leukoencephalopathy. Ann Neurol, in press.

  • Weber T, Trebst C, Frye S, Cinque P, Vago L, Sindic CJ, et al (1997). Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect Dis 176: 250–254.

    Article  CAS  PubMed  Google Scholar 

  • Willoughby E, Price RW, Padgett BL, Walker DL, Dupont B (1980). Progressive multifocal leukoencephalopathy (PML): in vitro cell-mediated immune responses to mitogens and JC virus. Neurology 30: 256–262.

    CAS  PubMed  Google Scholar 

  • Yiannoutsos CT, Major EO, Curfman B, Jensen PN, Gravell M, Hou J, Clifford JB, Hall CD (1999). Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy. Ann Neurol 45: 816–821.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Marienkrankenhaus, Hamburg, Germany

    Thomas Weber

  2. Section of Neurology, MPI of Psychiatry, Munich, Germany

    F. Weber

  3. Department of Virology and Immunology, German Primate Center, Göttingen, Germany

    H. Petry & W. Lüke

Authors
  1. Thomas Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Petry
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. Lüke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Weber.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weber, T., Weber, F., Petry, H. et al. Immune response in progressive multifocal leukoencephalopathy: An overview. Journal of NeuroVirology 7, 311–317 (2001). https://doi.org/10.1080/13550280152537166

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1080/13550280152537166

Keywords

Search

Navigation